Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Monoammonium Glycyrrhizinate Hydrate

Monoammonium Glycyrrhizinate Hydrate

53956-04-0

DISCOVER
Glycitin

Glycitin

40246-10-4

DISCOVER
Genistin

Genistin

529-59-9

DISCOVER
Gabapentin Related Compound E

Gabapentin Related Compound E

67950-95-2

DISCOVER
Glimepiride Impurity C

Glimepiride Impurity C

119018-30-3

DISCOVER
Ginsenoside Rb1

Ginsenoside Rb1

41753-43-9

DISCOVER
Hydroxyibuprofen-2

Hydroxyibuprofen-2

51146-55-5

DISCOVER
Hydroxycarbamazepine-2

Hydroxycarbamazepine-2

68011-66-5

DISCOVER
Hydroxycarbamazepine-3

Hydroxycarbamazepine-3

68011-67-6

DISCOVER
5-Hydroxymebendazole

5-Hydroxymebendazole

60254-95-7

DISCOVER
Hesperidin

Hesperidin

520-26-3

DISCOVER
Irganox MD 1024

Irganox MD 1024

32687-78-8

DISCOVER